期刊文献+

丹参酮ⅡA抑制氧化应激相关心肌肥大的研究 被引量:2

Study on tanshinone ⅡA in inhibiting oxidative stress related cardiac hypertrophy
下载PDF
导出
摘要 目的探讨丹参酮ⅡA对氧化应激相关心肌肥大的改善作用及相关机制。方法采用不同浓度的丹参酮ⅡA处理心肌肥大细胞(5-羟色胺刺激诱导),观察其对细胞的表面积、合成速度、活性氧水平的影响,并采用Elisa法和RT-PCR检测Apelin和Apelin mR-NA水平。结果①与DMSO相比,丹参酮ⅡA可抑制5-羟色胺刺激诱导新生大鼠的心肌细胞表面积增大,且在30μmol/L浓度下效果最明显;②丹参酮ⅡA可降低心肌细胞的合成速度以及活性氧水平;③丹参酮ⅡA处理后Apelin和Apelin mRNA水平上升;④F13A(Apelin受体的拮抗剂)可减弱丹参酮ⅡA抑制心肌肥大的作用。结论丹参酮ⅡA可改善氧化应激相关的心肌肥大,可能的机制是通过上调Apelin而实现。 Objective It is to approach the improving effects of tanshinone Ⅱ A towards oxidative stress related cardiac hy- pertrophy and related mechanism. Methods The cell of cardiac hypertrophy model induced by 5 - hydroxytryptamine (5 - HT) was treated by different concentrations of tanshinone Ⅱ A. The following items were studied such as cell surface area, leucine incorporation and ROS. The ELISA and RT - PCR were employed to test the level of Apelin and Apelin mRNA. Re- sults (1)Compared with DMSO, the increased surface area of neonatal rat myocardial cells stimulated by 5 - HT serotonin with the significant effects at 30 μmol/L was inhibited by tanshinone Ⅱ A ; (2) The synthesis rate of protein and reactive oxygen spe- cies level were reduced by tanshinone ⅡA; (3) The levels of Apelin and Apelin mRNA were elevated after tanshinone Ⅱ A treatment; (4)The effect of tanshinone Ⅱ A in suppressing cardiac hypertrophy was reduced by the antagonist of Apelin receptor F13A. Conclusion Tanshinone Ⅱ A can improve oxidative stress related cardiac hypertrophy with possible mechanism of up- regulating Apelin.
出处 《现代中西医结合杂志》 CAS 2012年第21期2301-2303,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
基金 国家自然科学基金资助项目(30500657)
关键词 丹参酮ⅡA APELIN 氧化应激 心肌肥厚 Tanshinone Ⅱ A Apelin oxidative stress cardiac hypertrophy
  • 相关文献

参考文献12

  • 1Gangopadhyay JP,ikemoto N. Aberrant interaction of calmodulin with the ryanodine receptor develops hypertrophy in the neonatal cardio- myocyte [ J ]. Biochem J ,2011,438 ( 2 ) :379 - 387.
  • 2Ling SL,Zhou LY,Li PF. MicroRNAs in cardiac hypertrophy: angels or devils [ J ]. Wiley lnterdiscip Rev RNA ,2011,2 ( 1 ) : 124 - 34.
  • 3Fu J,Huang H,Liu J,et al. Tanshinone II A protects cardiac myo- cytes against oxidative stress-triggered damage and apoptosis [ J ]. Eur J Pharmacol,2007,568(I/3) :213 -221.
  • 4Yang L,Zou X, Liang Q,et al. Sodium tanshinone II A sulfonate depresses angiotensin II- induced cardiomyocyte hypertrophy through MEK/ERK pathway[J]. Exp Mol Med,2007,39( 1 ) :65 -73.
  • 5Shan H,Li X,Pan Z,et al. Tanshinone II A protects against sudden cardiac death induced by lethal arrhythmias via repression of mi- croRNA - 1 [ J ]. Br J Pharmacol,2009,158 (5) : 1227 - 1235.
  • 6Wu S,Gao J,Ohlemeyer C,et al. Activation of AP - 1 through reac- tive oxygen species by angiotensin II in rat cardiomyocytes [ J ]. Free Radic Biol Med, 2005,39:1601 - 1610.
  • 7Liu X,Gai Y, Liu F,et al. Trimetazidine inhibits pressure overload- induced cardiac fibrosis through NADPH oxidase - ROS - CTGF pathway[J]. Cardiovasc Res,2010,88( 1 ) :150 - 158.
  • 8Alaaeddine N, De Montigny C,Sadouk M. Real-time reverse tran- scription-polymerase chain reaction quantification of tumor necrosis factor alpha messenger in human leukocytes[ J ]. Clin Lab,2011 ;57 (9/10) :799 - 802.
  • 9O' Carroll AM,Selby TL,Palkovits M,et al. Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues [ J ]. Biochim Biophys Acta,2000,1492 ( 1 ) : 72 - 80.
  • 10罗丽萍,王军英,王丽娅,司军强.Apelin的最新研究进展[J].农垦医学,2010,32(1):58-61. 被引量:2

二级参考文献25

  • 1余洋,黄德嘉.Apelin的研究进展[J].心脏杂志,2006,18(1):100-102. 被引量:2
  • 2曾翔俊,张立克,唐朝枢.Apelin/APJ系统在心血管系统中的作用[J].国际病理科学与临床杂志,2006,26(6):483-487. 被引量:4
  • 3O'Carroll A M,Selby T L,Palkovits M,et al.Distribution of mRNA encoding 878/apj,the rat homologue of the human APJ re-ceptor,and its endogenous ligand apelin in brain and peripheral tissues[J].Biochim Biophys Acta,2000,492:72-80.
  • 4Foldes G,Horkay F,Szokodi I,et al.Circulating and cardiac lev-els of apelin,the novel ligand of the orphan receptor APJ,in pa-tients with heart failure[J].Biochem Biophy Res commun,2003,308:480-48S.
  • 5Kleinz M J,Davenport A P.Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardia] endothelial cells[J].Regul Pept,2004,118:119-125.
  • 6Kleinz M J,Skepper J N,Davenport A P,et al.Immunocytochemi-cal localisation of the apelin receptor,APJ,to human cardiomyo-cytes,vascular smooth muscle and endothelial cells[J].Regul Pept,2005,126:233-240.
  • 7Kawamata Y,Habata Y,Fukusumi S.et al.Molecular properties of apelin:tissue distribution and receptor binding[J].Biochim Biophys Acat.2001,1538:162-171.
  • 8Lee D K,Cheng R,Nguyen T,et al.Characterization of apelin,the ligand for the APJ receptor[J].Journal of Neurochemistry,2000,74:34-41.
  • 9Lee D K,Saldivia V R,Nguyen T,et al.Modification of the ter-minal residue of apelin-13 antagonizes its hypotensive action[J].Endocrinology.2005,146:231-236.
  • 10Oudit C Y,Crackower M A,Backx PH,et al.The role of ACE2 in cardiovascular physiology[J].Trends Cardiovascular Med,2003,13,:93-101.

共引文献1

同被引文献6

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部